13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 48 holding rows worth $3,165,729,000.
- Accession
- 0001104659-20-062663
- Filer
- CIK 1346824
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 48 entries on the cover page, a total value of $3,165,729,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,165,729,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,914,955 | $553,473,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 4,858,260 | $233,245,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 4,176,910 | $167,828,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 3,672,872 | $148,017,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 5,275,538 | $130,464,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,904,094 | $112,018,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 2,162,671 | $105,949,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 10,387,411 | $102,212,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 4,681,858 | $100,754,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 4,127,348 | $99,593,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 3,707,408 | $95,725,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 10,874,613 | $95,588,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 5,422,312 | $82,528,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 3,161,214 | $79,821,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 4,524,961 | $77,920,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,775,207 | $72,854,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 7,272,714 | $71,054,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 2,531,445 | $68,855,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,589,904 | $64,618,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 4,166,453 | $60,789,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 10,364,658 | $57,048,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 982,723 | $55,180,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 18,604,651 | $49,116,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,379,988 | $47,071,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 548,000 | $40,968,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 3,240,534 | $39,502,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 6,416,684 | $36,479,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,165,184 | $34,722,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 12,541,888 | $34,114,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,961,209 | $28,830,000 | thousands by filing date | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 3,518,998 | $26,041,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 6,361,446 | $25,700,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,119,963 | $25,647,000 | thousands by filing date | |
| IMARA INC | 45249V107 | COM | 1,454,348 | $23,313,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 2,957,434 | $21,471,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 5,166,303 | $17,617,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 259,099 | $17,448,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,858,474 | $16,429,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 4,571,164 | $10,925,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 893,115 | $8,485,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 602,274 | $6,023,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 322,630 | $5,081,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 82,180 | $3,899,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 959,300 | $3,837,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 429,399 | $3,062,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 870,633 | $2,098,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 87,405 | $1,401,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 100,000 | $917,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-062663 | this filing | 2020-05-15 | acceptance time not in the bulk data set |